Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study

• Autori principali: Victor Romanenko (Autore), Irina Osipova (Autore), Anna Galustyan (Autore), Michael Scherbakov (Autore), Nathalie Baudson (Autore), Déborah Farhi (Autore), Luis Anaya (Autore), Sherine O. Kuriyakose (Autore), Nadia Meyer (Autore), Winnie Janssens (Autore)
• Natura: Libro
• Pubblicazione: Taylor & Francis Group, 2020-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

We assessed the immunogenicity and safety of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in children in Russian Federation aiming to support the registration of the vaccine in Russia. In this phase 3, non-randomized,...